+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06933212

Effects of the Mediterranean Diet on Stroke and Cognitive Decline in Patients with CADASIL and Cerebral Amyloid Angiopathy

Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2026-09-01

86

Participants Needed

1

Research Sites

121 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of the Mediterranean Diet on patients with CADASIL and Cerebral Amyloid Angiopathy CAA, focusing on stroke incidence and cognitive decline. The study has two phases Phase 1 is observational, assessing patients nutritional status, dietary habits, and their adherence to the Mediterranean Diet. It also examines links between diet adherence and stroke severity or cognitive deficits. Phase 2 is an interventional phase where participants follow either a Mediterranean Diet enriched with extra virgin olive oil, a Mediterranean Diet enriched with walnuts, or a low-fat control diet. The study evaluates how these diets influence stroke occurrence and cognitive changes over time. Participants will undergo assessments of nutritional status, body composition, basal metabolism, and energy expenditure at baseline and throughout the study, which lasts up to 12 months. Researchers will monitor stroke incidence and cognitive decline, as well as adherence to the Mediterranean Diet at regular intervals to understand the impact of diet on these health outcomes.

CONDITIONS

Brief Title

Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.

Research Team

A

Anna Bersano, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here